Comment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
- PMID: 26372699
- PMCID: PMC4705879
- DOI: 10.1038/bjc.2015.331
Comment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
Comment in
-
Reply: Comment on 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colo-rectal cancer'.Br J Cancer. 2015 Dec 1;113(11):1637-8. doi: 10.1038/bjc.2015.330. Epub 2015 Sep 15. Br J Cancer. 2015. PMID: 26372702 Free PMC article. No abstract available.
Comment on
-
KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.Br J Cancer. 2015 Feb 17;112(4):720-8. doi: 10.1038/bjc.2014.499. Br J Cancer. 2015. PMID: 25688918 Free PMC article.
References
-
- Fiorentino F, Treasure T (2013. a) Pulmonary metastasectomy: are observational studies sufficient evidence for effectiveness? Ann Thorac Surg 96: 1129–1131. - PubMed
-
- Fiorentino F, Treasure T (2013. b) Pulmonary metastasectomy for colorectal cancer: making the case for a randomized controlled trial in the zone of uncertainty. J Thorac Cardiovasc Surg 146: 748–752. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous